Inventor · disambiguated record
Alessio Ciulli
Also filed as: CIULLI ALESSIO
6 granted patents·9 pending applications·16 citations·filing 2013–2024
72Inventor score
Files withUNIV DUNDEE7UNIV YALE3AMPHISTA THERAPEUTICS LTD2BOEHRINGER INGELHEIM INT2BOEHRINGER INGELHEIM INTL GMBH CORP1
Top patents by PatentIndex Score
15 records- 0191US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 0274US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 0358US11179373B2Derivatives of 1-[(cyclopentyl or 2-pyrrolidinyl)carbonylaminomethyl]-4-(l,3-thiazol-5-yl) benzene which are useful for the treatment of proliferative, autoimmune or inflammatory diseasesUNIV DUNDEE·Filed 2016·Granted Nov 23, 2021·1 cites·10 claims
- 0457US2025130239A1Protein degraderUNIV DUNDEE·Filed 2022·Application pending·0 cites
- 0555US2025049929A1Novel tetrahydroquinolines and proteolysis targeting chimera (protacs) comprising them as degraders of smarcaBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0654US2022127257A1Small moleculesUNIV DUNDEE·Filed 2022·Application pending·0 cites
- 0754US2019127359A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2018·Application pending·0 cites
- 0853US11925690B2Bifunctional molecules for targeting Rpn11AMPHISTA THERAPEUTICS LTD·Filed 2019·Granted Mar 12, 2024·0 cites·2 claims
- 0952US2025145608A1Kras degrading compounds comprising annulated 2-amino-3-cyano thiophenesBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1047US2024252654A1Improved small moleculesUNIV DUNDEE·Filed 2021·Application pending·0 cites
- 1146US11261179B2Small moleculesUNIV DUNDEE·Filed 2018·Granted Mar 1, 2022·0 cites·17 claims
- 1243US12187719B2Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and /or SMARCA4BOEHRINGER INGELHEIM INT·Filed 2019·Granted Jan 7, 2025·0 cites·21 claims
- 1339US11234988B2Fluorohydroxyproline derivatives useful in the preparation of proteolysis targeted chimerasUNIV DUNDEE·Filed 2017·Granted Feb 1, 2022·0 cites·19 claims
- 1437US2017122958A1Enzymes Functional ProbesUNIV DUNDEE·Filed 2014·Application pending·0 cites
- 1532US2021283139A1Bifunctional molecules for targeting uchl5AMPHISTA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alessio Ciulli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →